NMN Dosage: How Much Per Day? 250mg vs 600mg vs 1000mg

Key Takeaways

Dose-response data from the largest NMN RCT to date shows 600 mg/day as the point where NAD+ elevation and physical performance plateau. Higher doses provided no additional benefit. The multicenter trial randomized middle-aged adults across four NMN supplement dose groups and measured walking endurance, grip strength, and blood NAD+ levels over 60 days (Yi et al., 2023, GeroScience). For the question of how much NMN per day, the clinical data supports 250–600 mg as the effective range, with 600 mg offering the best balance of NAD+ boosting and cost efficiency.

Quick Answer: The clinical sweet spot is 500–600 mg NMN per day. The Yi et al. 2023 RCT (n=80, 60 days) pinpointed 600 mg as the dose where blood NAD+ elevation and walking-distance gains both peaked, and 900 mg did not add measurable benefit. Lower doses of 250–300 mg still raised NAD+ severalfold in older adults. The 2026 Christen et al. Nature Metabolism trial confirmed 1,000 mg roughly doubles circulating NAD+ within 14 days. Take it once daily, in the morning, with food. No loading phase needed.

NMN dosing is unusually well-mapped. As of May 2026, at least a dozen peer-reviewed human trials have tested specific protocols: from 125 mg twice daily up to 1,200 mg. This guide walks through every tested dose, what each one delivered, what the critics still argue about, and how to pick the amount that fits your goal and budget.

What does every NMN study dose?

Before drilling into individual doses, here is what the human-trial record actually contains. The table below is built from the eight largest peer-reviewed NMN trials in healthy and prediabetic adults, with the specific dose, sample size, duration, and the headline NAD+ or functional outcome each reported.

Two patterns jump out. One, 250 mg is enough to move whole-blood NAD+ in older adults. You do not need a thousand-milligram dose to see the basic biomarker shift. Two, the dose-response is not linear past 600 mg. Yi's data is the most credible read on the ceiling: 900 mg matched 600 mg on every functional measure, suggesting the body's conversion machinery saturates somewhere in that range.

How much NMN should you take for your goal?

Unlike most supplements where dosing recommendations come from tradition, NMN has been tested at specific milligrams in controlled trials. Match your goal to the evidence-backed dose. Is 125 mg twice daily (250 mg/day) effective? Some brands split a 250 mg dose into two 125 mg servings to smooth absorption.

Is 125 mg twice daily (250 mg/day) effective?

Some brands split a 250 mg dose into two 125 mg servings to smooth absorption. There is no clinical evidence that splitting is meaningfully better than a single morning dose, but it can help if higher single doses cause mild stomach upset. Stick with one morning dose unless you have a specific reason to split.

Is 250 mg/day the workhorse NMN dose?

This is the most frequently tested dose in published NMN trials. According to Igarashi et al. (2022, NPJ Aging), 250 mg/day for 12 weeks raised whole-blood NAD+ roughly sixfold in 42 healthy men over 65. Gait speed and left-hand grip strength showed nominally significant improvements.

Okabe et al. (2022, Endocrine Journal) confirmed that 250 mg/day for 12 weeks raised NAD+ by roughly 75% in 29 healthy adults aged 20–65. No blood-panel, blood-pressure, or body-composition changes, but no safety flags either.

Kim et al. (2022, Biomedical Research) tested 250 mg/day for 12 weeks in 108 older adults. Afternoon dosing reduced drowsiness scores; sleep quality improvements were most consistent in the PM group; the one published exception to the "morning is better" rule.

And the Yoshino group's 2021 Science trial (PMID 33888596) used the same 250 mg/day dose for 10 weeks in 25 prediabetic postmenopausal women. Muscle insulin sensitivity improved, though, as we cover below in the counter-arguments section, that trial's randomization was later questioned.

If you are new to NMN, 250 mg/day is the evidence-backed starting point. It reliably raises NAD+, has the deepest safety dataset across age groups, and shows functional improvements in independent trials.

What does 300 mg/day of NMN do?

Huang et al. (2022, Frontiers in Aging) tested 300 mg/day (split 150 mg twice daily) in 66 adults aged 40–65 for 60 days. NAD+/NADH rose 38% versus 14.3% in placebo. SF-36 health scores improved; functional outcomes did not reach statistical significance.

A separate Niu et al. (2021, Frontiers in Nutrition) pilot reported that 300 mg/day for 90 days nearly doubled peripheral blood telomere length in eight men aged 45–60. That headline gets quoted a lot, but the trial was non-blinded, had no placebo control, and ran with only eight participants. It is suggestive, not confirmatory.

In the Yi multicenter RCT, 300 mg was the lowest active arm. NAD+ rose significantly versus placebo, but the within-group walking-distance change at day 60 was not statistically meaningful at this dose, only the 600 mg and 900 mg groups crossed that threshold.

Is 500 mg/day the commercial standard?

No major RCT has used 500 mg/day as its exact arm, but the dose sits squarely between the 300 mg lower bound and the 600 mg empirical optimum. Most reputable supplement brands settle here because it captures most of the NAD+ benefit at a meaningfully lower per-capsule cost than 600 mg or 1,000 mg.

This is also the dose we use in our own YourHealthier NMN, and we are transparent that it is a pragmatic call, not a "more is better" position. See the Why We Recommend 500 mg section below for the full reasoning.

Why is 600 mg/day the empirical optimum?

According to Yi et al. (2023, GeroScience), a multicenter, double-blind, placebo-controlled RCT in 80 middle-aged adults (40–65 years), 600 mg/day produced the highest combination of NAD+ elevation and functional improvement. The 600 mg group walked significantly further at both day 30 and day 60, and significantly outperformed the 300 mg group on six-minute walking distance.

The 900 mg group hit similar NAD+ levels but did not outperform 600 mg on any functional measure. If you want the dose with the cleanest benefit-to-cost ratio in the published record, this is it.

Does 900 mg/day of NMN add more benefit?

Yi tested 900 mg/day in the same RCT. NAD+ elevation was comparable to 600 mg. No additional safety signals versus lower doses. Plateau effect. If you are paying for 900 mg expecting 50% more benefit than 600 mg, the data does not support that expectation.

What is the 1,000 mg "Sinclair dose"?

Harvard geneticist David Sinclair, PhD, has publicly stated he takes 1 gram of NMN every morning, paired with resveratrol and yogurt. His personal protocol is not clinical evidence, but the 2026 Christen et al. study (Nature Metabolism) used exactly that dose: 1,000 mg/day, in 65 healthy participants. After 14 days, circulating NAD+ had roughly doubled. The same trial gave another arm 1,000 mg of nicotinamide riboside (NR) and saw a comparable rise. That parallel is important; we return to it in the counter-arguments section.

Is 1,200 mg/day the upper safe limit?

Across published human trials, 1,200 mg/day is roughly the upper boundary that has been examined for short-term use without serious adverse events (Examine database synthesis of NMN safety literature, updated 2026). There is no efficacy reason, based on current data, to exceed it, and the Yi plateau makes it unlikely you would notice the difference if you did.

How does NMN dose affect NAD+ levels?

NAD+ rises with NMN dose but plateaus. Trials show clear increases from 250 mg upward, with 600 mg/day producing the best balance of NAD+ elevation and value in the Yi (2023) RCT. Doses of 900 to 1,200 mg add little extra NAD+, so more is not proportionally better.

The curve flattens at roughly 600 mg. Going from 600 to 900 mg buys very little extra NAD+ in the published data; going from 900 to 1,000 mg buys essentially nothing.

When to Take NMN: Morning vs Night

Take NMN in the morning. NAD+ levels naturally peak in the morning and decline toward evening through the SIRT1–CLOCK/BMAL1 circadian pathway. Aligning the dose with that rhythm matches the protocols used in nearly every successful trial.

The exception is Kim et al. (2022), which found afternoon dosing improved sleep-related outcomes. If you are specifically targeting sleep quality, an afternoon dose is defensible. For every other goal: longevity, energy, physical performance, insulin sensitivity, morning wins. For a deeper breakdown, see our Best Time to Take NMN guide.

Splitting the dose (morning + early afternoon) is reasonable above 600 mg if you prefer. Avoid evening dosing unless you have a specific sleep-targeted reason.

How Long Before You See Results?

Blood NAD+ levels begin rising within the first two weeks of supplementation. The 2026 Christen et al. trial confirmed NAD+ doubling at the 14-day mark. Functional benefits: walking distance, energy, sleep quality, generally need 4 to 12 weeks.

Week 1–2: Whole-blood NAD+ measurably rises. No noticeable functional changes yet.

Week 4: The Yi trial saw some participants reporting improved energy and walking distance by day 30. Earliest functional signal in the literature.

Week 6–8: Most physical-performance, sleep, and metabolic-marker trials see their primary endpoints here.

Week 12: Endpoint for Igarashi, Okabe, and Kim. Gait speed and grip strength results live in this window. The most common trial duration.

If you have taken NMN consistently for 12 weeks at 250+ mg/day and notice nothing, it may not be your supplement. NMN raises NAD+ reliably in nearly everyone, but the downstream functional benefits vary by age, baseline health, sleep, and activity level. Real-world expectations are covered in our NMN Before and After breakdown.

Do You Need a Loading Phase?

No. No published NMN trial has used a loading-phase protocol. All positive results come from steady daily dosing at a fixed amount. This is the opposite of creatine, where loading is well-established, see our creatine loading guide for that contrast.

Some brands recommend "loading" with higher NMN doses for the first week. There is no clinical basis for it. Start at your target dose, hold it. The Christen 2026 trial showed that even 1,000 mg/day produced NAD+ doubling within 14 days without any loading.

NMN and Food: With or Without?

Most clinical trials administered NMN before breakfast (fasted). Sinclair has said he takes it with yogurt for the fat content, but that has never been tested in a controlled comparison.

Practical rule: take NMN in the morning, with a light meal if your stomach is sensitive, fasted if not. Consistency of timing matters more than presence or absence of food. The food question for our other products is covered in a parallel guide for magnesium glycinate timing.

Who Should Be Cautious

Most healthy adults tolerate NMN well, but some should be cautious. Anyone pregnant, breastfeeding, on cancer treatment, or managing a serious condition should check with a doctor first, since long-term and disease-specific safety data is still thin. NMN's effects are metabolic and measured on bloodwork, not immediately felt.

NMN has shown no serious adverse events at any tested dose up to 1,200 mg/day. But specific groups should start conservatively at 250 mg/day for 2 to 4 weeks before considering an increase.

Adults over 65: 250 mg/day is the dose with the most safety data in older populations (Igarashi, Kim, Okabe). Start here.

Anyone on multiple supplements: Introduce NMN alone first so you can isolate its effects. Stacks make attribution impossible.

Sensitive digestive systems: Mild GI discomfort has been occasionally reported (not formally attributed to NMN by investigators). Take with food at higher doses.

Pregnant or nursing: No human-pregnancy data exists. Avoid.

People with active or prior cancer: NAD+ supports cellular metabolism broadly, including potentially cancer-cell metabolism. The long-term safety question raised by oncology researchers is not settled. Talk to your oncologist.

People taking medications: No clinically significant NMN-drug interactions have been reported in trials, but trials are short and small. Run it past your prescriber.

What the Critics Say

NMN is one of the most contested supplements in longevity research. Three lines of criticism deserve attention before you commit to a dose. We are not going to skip them.

1. Charles Brenner: "NMN has to convert to NR to enter cells"

Charles Brenner, PhD, the discoverer of nicotinamide riboside (NR), has consistently argued that NMN cannot cross the cell membrane directly in humans. His position: extracellular CD73 strips the phosphate off NMN, converting it back to NR, which then enters the cell and is re-phosphorylated to NMN inside. If that mechanism is dominant, NR is the more efficient precursor, fewer conversion steps.

Brenner also published a formal comment (Science 2021, PMID 34326206) criticizing the Yoshino prediabetic-women trial. His objection: the NMN group had a baseline hepatic-lipid content of 6.3% versus 14.8% in placebo (p=0.003). Given that liver-fat reduction is a target of NMN, the groups were not effectively randomized at baseline.

The 2026 Christen Nature Metabolism trial complicates the picture. NR and NMN raised circulating NAD+ to a comparable degree at 1,000 mg/day: neither was clearly superior. Brenner's "NR is more efficient" claim is not refuted, but the practical gap appears smaller than he has argued. For a head-to-head, see our NMN vs NR comparison.

2. The metabolic-framing objection

A separate Science letter pointed out that the Yoshino trial used a "prediabetes" framing, a diagnostic category some researchers consider weakly supported. This does not invalidate the insulin-sensitivity finding, but it puts the clinical-relevance claim on softer ground than the headline suggests.

3. The Sinclair-dose question

Sinclair takes 1 gram daily. The Yi data says you stop getting extra benefit above 600 mg. If Sinclair is right and 1 gram is meaningfully better, the controlled-trial record has not caught up. If the trials are right, 1 gram is overspending, and that is the more parsimonious read of the evidence as of May 2026. For more, see our why some discontinue NMN guide.

4. The FDA history

In November 2022, the FDA excluded NMN from the dietary-supplement definition because the molecule had been authorized for investigation as a drug (MIB-626). The Natural Products Association sued; in letters dated December 2, 2025, the FDA confirmed NMN is again lawful as a US dietary supplement, reversing the 2022 position. EU status is still under Novel Food review. The molecule itself was not the problem; the regulatory pathway was.

None of these criticisms invalidate NMN. They do mean honest dosing recommendations should not pretend the field is settled.

How much do top NMN brands cost per dose?

Doses vary 3x across mainstream brands, and so do prices. Product comparison: dosage, testing, and value across leading brands Brand & Product NMN / Serving Approx Price Notes YourHealthier NMN 500 mg See product page Third-party tested; cGMP; transparent COA Tru Niagen NMN+ 300 mg ~$60 / 30 servings NMN line from ChromaDex (originally NR-focused) ProHealth Longevity NMN Pro Complete 1,000 mg ~$120+ / 30

Two things to notice. To start, the high-dose products (ProHealth, Wonderfeel) cost roughly 2 to 3× the mid-dose options without published evidence that the extra milligrams add benefit. Then, the lower-dose Tru Niagen NMN+ at 300 mg lands in the "active but suboptimal" range: fine for new users, light for anyone targeting the 500–600 mg sweet spot.

Why We Recommend 500 mg

We sell a 500 mg NMN capsule. We do not pretend that choice is purely scientific. It is also a pragmatic call. Here is the reasoning, transparent. The published optimum is 600 mg (Yi). 500 mg sits one capsule below that, in a range where every published trial saw NAD+ elevation.

500 mg sits one capsule below that, in a range where every published trial saw NAD+ elevation. The gap between 500 mg and 600 mg is small, almost certainly within individual response variability. The gap between 500 mg and 1,000 mg is large in cost, small in measured benefit.

For customers who want to mirror Yi's exact protocol or follow Sinclair's 1 g approach, two of our 500 mg capsules deliver 1,000 mg without paying the high-dose premium. For new users, one capsule per day starts at a dose well inside the evidence-backed range and leaves room to increase if they want to.

That is the honest case. If your priority is matching the 600 mg optimum exactly, a 600 mg product is a defensible choice, there are not many on the market, but they exist. The 500 mg standard exists because it captures most of the benefit at a meaningfully lower cost than 1,000 mg, which is what most US buyers actually care about.

NMN, NAD+ and the Dosing Debate, on Video

David Sinclair discusses NMN dosing, NAD+ decline with age, and his personal 1g protocol on the Lex Fridman Podcast (Episode 189). Useful context for understanding the "Sinclair dose" referenced throughout this article.

Related Research

• PubMed: 27721479
• PubMed: 36476934
• PubMed: 27304511
• DOI: 10.1002/fft2.511
• PubMed: 17086191
• PubMed: 21261636
• PubMed: 35927255
• PubMed: 20528005

Related Reading

• NMN And Resveratrol
• NMN vs Nad

What's new in NMN research (2025–2026)?

The NMN trial count cleared a dozen published RCTs by 2026, spanning dose ranges from 250 mg to 1,250 mg daily. The consistent finding: NAD+ levels go up, side effects stay mild, and longer-duration data is still the gap to watch.

Why should you start with a low NMN dose?

The clinical trial protocols for NMN overwhelmingly use a start-low approach, and there are practical reasons to replicate this even though serious adverse events have not been observed at any studied dose. The Igarashi 2022 trial started participants at 250 mg/day; the Yi 2023 trial used 300 mg escalating to 600 mg; and the Yoshino 2021 trial held at 250 mg throughout.

Starting at 250 mg for the first 1 to 2 weeks serves three purposes. For starters, it identifies the 10 to 12% of users who experience mild GI adjustment at any dose, allowing them to troubleshoot (taking with food, switching timing) before escalating. Next, it establishes a baseline experience against which higher doses can be meaningfully compared. If you start at 1,000 mg and feel "more energetic," you cannot distinguish between placebo effect, caffeine timing changes, and genuine NMN response. Starting low creates a reference point. Three, it respects the fact that NMN is raising NAD+ levels in every tissue simultaneously, and a gradual increase allows enzymatic systems (particularly PARPs and sirtuins) to upregulate in proportion to substrate availability.

The common dose tiers used across published trials: 250 mg/day is the starting and maintenance dose with the most safety data. 500 mg/day is the dose used in exercise performance studies (Kim 2022) and appears to be the sweet spot for most adults based on blood NAD+ dose-response curves. 1,000 to 1,250 mg/day represents the upper end of tested doses and showed additional NAD+ elevation without increased side effects, though whether the additional NAD+ translates to additional clinical benefits is not established.

How should you escalate your NMN dose?

If you are starting NMN for the first time, a graduated approach reduces the risk of GI adjustment while establishing a response baseline. Week 1 to 2: 250 mg/day in the morning with breakfast. Monitor for any GI discomfort, headache, or sleep disruption. If well-tolerated, this becomes your maintenance floor. Week 3 to 4: increase to 500 mg/day (either as a single morning dose or split 250 mg morning + 250 mg with lunch). This is the dose used in the Kim 2022 exercise performance study and represents the best-supported balance of efficacy and tolerability. Week 5 to 8: assess subjectively and, ideally, test blood NAD+ levels. If 500 mg produces satisfactory results, maintain this dose. If you want to explore higher doses, increase to 750 mg or 1,000 mg in week 5 and reassess at week 8. Doses above 1,000 mg/day are at the upper end of the tested range and should be approached with physician awareness.

For people taking multiple supplements alongside NMN: there are no documented absorption conflicts between NMN and common supplements (magnesium, vitamin D, omega-3, CoQ10, ashwagandha). NMN can be taken at the same time as these compounds without timing separation concerns. The only consideration is taking NMN with food (any food) to reduce the 10 to 12% incidence of mild GI adjustment that occurs with empty-stomach dosing.

How does NMN dosing differ by population?

While most NMN trials enrolled healthy middle-aged adults, the compound's relevance varies by population. For athletes: the Kim 2022 study used 600 mg/day and found improved aerobic capacity metrics. Athletes with high training volumes may benefit from higher doses (500 to 1,000 mg) due to increased NAD+ consumption during exercise recovery. For older adults (60+): NAD+ decline is most pronounced in this demographic, suggesting greater absolute benefit from supplementation. Start at 250 mg and escalate to 500 mg based on tolerance. For people with metabolic syndrome: NMN's insulin-sensitizing effect (Yoshino 2021) is most relevant here; 250 mg/day showed measurable improvement in insulin-mediated glucose disposal.

Why YourHealthier NMN

An NMN supplement is only worth taking if it's genuinely pure, and the cheap end of the market is exactly where purity slips. Our NMN delivers 500mg of β-Nicotinamide Mononucleotide per capsule at high purity, with third-party testing for identity and contaminants. We're deliberately not making the longevity promises that fill most NMN marketing. What the human research currently supports is that NMN raises NAD+, while the anti-aging effects seen in mice remain unproven in people. Our job, as we see it, is the simpler one: give you a clean capsule whose contents match the label. For a molecule this expensive to manufacture, a third-party certificate of analysis is the practical line between genuine NMN and underdosed filler.

Frequently Asked Questions

Related Reading:

• NMN Benefits: What NAD+ Actually Does for Aging and Energy (2026)
• NMN vs NR: Which NAD+ Precursor Is Better? (2026 Data)
• NMN Side Effects: What the Clinical Trials Report (2026)
• Best Time to Take NMN: Morning or Night? (2026 Guide)
• NMN Before and After: Real Results from 8-Week Use (2026)
• Creatine Dosage: Loading vs Maintenance. What the Research Says
• Creatine for Brain Health: Not Just for Athletes (2026)
• How Long Does Creatine Take to Work? Week-by-Week Timeline
• Berberine Dosage: How Much Per Day? 500mg vs 1500mg Explained
• Lion's Mane Dosage: How Much Should You Take?
• Best Time to Take Berberine for Weight Loss: Morning or Night?
• Best Time to Take Ashwagandha: Morning, Night, or Both?
• Magnesium Glycinate: Empty Stomach or With Food?
• Shilajit Benefits: 8 Effects Ranked by Evidence (2026)
• Best Supplements for Sleep: A Science-Based Ranking (2026)
• Ashwagandha Benefits: 7 Reasons It's the Most Popular Adaptogen
• Berberine Benefits: What It Does for Blood Sugar, Metabolism, and More
• Magnesium Glycinate Benefits: 7 Reasons It Beats Other Forms (2026)

References

1. Christen S, Redeuil K, Goulet L, et al. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nature Metabolism. 2026;8(1):62–73. PubMed
2. Yi L, Maier AB, Tao R, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. 2023;45(1):29–43. PubMed
3. Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224–1229. PubMed
4. Brenner C. Comment on "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women." Science. 2021;373(6554):eabj1696. PubMed
5. Igarashi M, Nakagawa-Nagahama Y, Miura M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood NAD levels and alters muscle function in healthy older men. NPJ Aging. 2022;8:5. PubMed
6. Huang H. A multicentre, randomised, double blind, parallel design, placebo controlled study to evaluate the efficacy and safety of Uthever (NMN supplement). Frontiers in Aging. 2022;3:851698. PubMed
7. Niu KM, Bao T, Gao L, et al. The impacts of short-term NMN supplementation on serum metabolism, fecal microbiota, and telomere length in pre-aging phase. Frontiers in Nutrition. 2021;8:756243. PubMed
8. Song Q, Zhou X, Xu K, et al. The safety and antiaging effects of nicotinamide mononucleotide in human clinical trials: an update. Advances in Nutrition. 2023;14(6):1416–1435. PubMed

Disclosure: YourHealthier sells NMN supplements. This article is written by our editorial team based on peer-reviewed research. We cite only published clinical trials and disclose where the evidence is limited or contested. See our Editorial Policy for how we research and write.

How Long for Nmn to Start Working?

Blood NAD+ begins rising within days of starting NMN. A 2023 trial (PMID: 36482258) measured significantly elevated NAD+ after 12 weeks at 250 mg/day. Subjective effects like better energy are typically reported after 2–4 weeks, though responses vary. Measurable changes required the full 8–12 week trials. NMN works through chronic replenishment, not acute stimulation—expect gradual improvement with consistent daily dosing.

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not intended as medical advice.

NMN Dosage: 600 mg Is the Ceiling

Metric	Value
Clinical sweet spot (mg/day)	500-600 mg
Low dose still works (mg/day)	250 mg
No added benefit above (mg)	900 mg
NAD+ rise at 250 mg (fold)	~6-fold
Source: YourHealthier · Yi 2023 RCT (n=80); Igarashi 2022

Chart: NMN Dosage: 600 mg Is the Ceiling. Data: Clinical sweet spot (mg/day): 500-600 mg; Low dose still works (mg/day): 250 mg; No added benefit above (mg): 900 mg; NAD+ rise at 250 mg (fold): ~6-fold. Source: Yi 2023 RCT (n=80); Igarashi 2022.